Kamedi GmbH is a medtech start-up based in Germany, founded in 2018. The company's flagship product, heat it®, offers a smart solution for treating itchy insect bites using a smartphone. This innovative product, available since summer 2020, provides quick relief by applying heat within seconds. It is designed to be portable, eco-friendly, and suitable for both adults and children (from 4 years, self-application from 12 years). The most recent investment, a Non Equity Assistance investment, was received on 15 March 2023, with SXSW Pitch participating as the investors. Kamedi GmbH's commitment to leveraging technology for medical solutions aligns with the growing demand for convenient healthcare products. As the company continues to expand its product line and reach, it presents an opportunity for venture capitalists seeking to invest in disruptive medtech innovations. The imprint and privacy policy links provided offer transparency and accountability, enhancing the company's credibility in the market.
Funding Stage | Amount | No. Investors | Investors | Date |
---|---|---|---|---|
Non Equity Assistance | Unknown | 1 | SXSW Pitch | 15 Mar 2023 |
Seed Round | Unknown | 4 | Daniel Stammler, Janosch Kühn +2 | 29 Mar 2021 |
Pre Seed Round | Unknown | 1 | Hoepfner Brau | 01 Jan 2019 |
No recent news or press coverage available for heat it® by Kamedi GmbH.